<bill session="118" type="s" number="2764" updated="2025-11-19T04:50:31Z">
  <state datetime="2023-09-12">REFERRED</state>
  <status>
    <introduced datetime="2023-09-12"/>
  </status>
  <introduced datetime="2023-09-12"/>
  <titles>
    <title type="display">Protecting Patient Access to Cancer and Complex Therapies Act of 2023</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation.</title>
    <title type="short" as="introduced">Protecting Patient Access to Cancer and Complex Therapies Act of 2023</title>
  </titles>
  <sponsor bioguide_id="B001261"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2024-11-12"/>
  </cosponsors>
  <actions>
    <action datetime="2023-09-12">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-09-12" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="5391" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Health care costs and insurance"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
</bill>
